| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 312 |
| 1 | BEVACIZUMAB | 172 |
| 2 | AFLIBERCEPT | 152 |
| 3 | VERTEPORFIN FOR INJECTION | 58 |
| 4 | FARICIMAB | 40 |
| 5 | TRAMETINIB | 35 |
| 6 | POVIDONE-IODINE | 25 |
| 7 | BINIMETINIB | 24 |
| 8 | DABRAFENIB | 23 |
| 9 | ENCORAFENIB | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VERTEPORFIN FOR INJECTION | 58 | 0.0392 |
| 1 | TROPICAMIDE | 21 | 0.0129 |
| 2 | RANIBIZUMAB | 312 | 0.0118 |
| 3 | POVIDONE-IODINE | 25 | 0.0058 |
| 4 | AFLIBERCEPT | 152 | 0.0048 |
| 5 | FARICIMAB | 40 | 0.0045 |
| 6 | ERDAFITINIB | 5 | 0.0040 |
| 7 | BINIMETINIB | 24 | 0.0030 |
| 8 | AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE | 3 | 0.0027 |
| 9 | ENCORAFENIB | 22 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 517 |
| 1 | Corticosteroid [EPC] | 63 |
| 2 | Photoenhancer [EPC] | 58 |
| 3 | Kinase Inhibitor [EPC] | 34 |
| 4 | Antiseptic [EPC] | 25 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 6 | Anticholinergic [EPC] | 21 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 20 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 17 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoenhancer [EPC] | 58 | 0.0149 |
| 1 | Antiseptic [EPC] | 25 | 0.0057 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 517 | 0.0028 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 10 | 0.0023 |
| 4 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 5 | Anticholinergic [EPC] | 21 | 0.0013 |
| 6 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 7 | Quinolone Antimicrobial [EPC] | 7 | 0.0007 |
| 8 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |